Skip to main content

Table 3 Multi-drug resistance pattern of GBS isolated from pregnant women recruited from two health institutions (n = 43)

From: Analysis of virulence factors and antibiotic resistance genes in group B streptococcus from clinical samples

Pattern Drugs resistance pattern (Antibiogram) No. of drug to which strains were resistant No. of MDR strains (%)
I AMP:PEN:CEFA:VAN:TET 5 3/29 (10.3%)
II AMP:PEN:CEFA:CLN:TET 5 2/29 (6.9%)
III AMP:PEN:CEFA:CHL:TET 5 1/29 (3.4%)
IV AMP:PEN:CLN:CRO:TET 5 1/29 (3.4%)
V AMP:CEFA:CLN:CRO:TET 5 1/29 (3.4%)
VI PEN:CEFA:CLN:CRO:TET 5 1/29 (3.4%)
VII CEFA:ERY:CLN:CHL:TET 5 1/29 (3.4%)
VIII AMP:PEN:CEFA:ERY:CRO:TET 6 1/29 (3.4%)
IX AMP:PEN:CEFA:CLN:CRO:TET 6 1/29 (3.4%)
X PEN:CEFA:CLN:CHL:CRO:TET 6 1/29 (3.4%)
XI PEN:ERY:CLN:CHL:CRO:TET 6 1/29 (3.4%)
XII CEFA:ERY:CLN:CHL:CRO:TET 6 1/29 (3.4%)
XIII AMP:PEN:CEFA:VAN:ERY:CLN:TET 7 3/29 (10.3%)
XIV AMP:PEN:CEFA:VAN:CLN:CRO:TET 7 1/29 (3.4%)
XV AMP:PEN:CEFA:ERY:CLN:CRO:TET 7 1/29 (3.4%)
XVI AMP:PEN:CEFA:VAN:CHL:CRO:TET 7 1/29 (3.4%)
XVII AMP:PEN:CEFA:CLN:CHL:CRO:TET 7 1/29 (3.4%)
XVIII AMP:PEN:CEFA:VAN:CLN:CHL:CRO:TET 8 3/29 (10.3%)
XXIV AMP:PEN:CEFA:ERY:CLN:CHL:CRO:TET 8 2/29 (6.9%)
XXX AMP:PEN:CEFA:VAN:ERY:CLN:CHL:TET 8 1/29 (3.4%)
XXXI AMP:PEN:CEFA:VAN:ERY:CLN:CHL:CRO:TET 9 1/29 (3.4%)
  1. AMP Ampicillin, PEN Penicillin G, CEFA Cefazolin, VAN Vancomycin, ERY, Erythromycin, CLN Clindamycin, CHL Chloramphenicol, CRO Ceftriaxone, TET Tetracycline (based on disk diffusion method)
\